The Move for Your Health Pilot Study

Sponsor
Cindy Blair, PhD, MPH (Other)
Overall Status
Completed
CT.gov ID
NCT03632694
Collaborator
University of New Mexico Cancer Center (Other), American Cancer Society, Inc. (Other)
54
3
12.5

Study Details

Study Description

Brief Summary

The Move for Your Health Pilot Study is a 16-week study in older cancer survivors to replace and break-up sedentary activity with short bouts of light physical activity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health Coaching and Tech Support
  • Behavioral: Tech Support Only
N/A

Detailed Description

This pilot study will determine the feasibility and acceptability of a mobile health (mHealth) intervention to replace and break-up sedentary time with intermittent bouts of light physical activity. The intervention uses an electronic activity monitor ("Jawbone UP2"; worn on the wrist) that pairs with a mobile app, which together promote awareness and enable self-monitoring of both physical activity (steps per day) and inactivity (wristband gently vibrates after a specified time of inactivity). Pre-post intervention change in objective, subjective, and biologic data will be compared between groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
3-arm randomized controlled trial; participants were block randomized with equal allocation to 3 arms within 2 strata defined by body mass index (BMI; <30 vs. >=30 kg/m2)3-arm randomized controlled trial; participants were block randomized with equal allocation to 3 arms within 2 strata defined by body mass index (BMI; <30 vs. >=30 kg/m2)
Masking:
Single (Investigator)
Primary Purpose:
Supportive Care
Official Title:
Replacing Sedentary Time With Light Activity
Actual Study Start Date :
Jul 6, 2016
Actual Primary Completion Date :
Jul 20, 2017
Actual Study Completion Date :
Jul 20, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Health Coaching and Tech Support

Participants receive tech support for using the "Jawbone UP2" activity monitor and smartphone app, and education materials and health coaching to achieve their goals to reduce sedentary time and increase their daily steps.

Behavioral: Health Coaching and Tech Support
Participants will receive a "Jawbone UP2" activity monitor and education materials about the negative consequences of sedentary behavior and suggestions for breaking up sedentary time with light physical activity. Participants receive 5 telephone coaching calls to set up the "Jawbone UP2" monitor with their smartphone app and receive tech support help with changing the settings/goals on the app. Additionally, this arm receives health coaching to provide encouragement and further motivate and help study participants to modify their sedentary behavior.

Active Comparator: Tech Support Only

Participants receive tech support for using the "Jawbone UP2" activity monitor and smartphone app and education materials on reducing sedentary behavior.

Behavioral: Tech Support Only
Participants will receive a "Jawbone UP2" activity monitor and education materials about the negative consequences of sedentary behavior and suggestions for breaking up sedentary time with light physical activity. Participants receive 5 telephone coaching calls to set up the "Jawbone UP2" monitor with their smartphone app and receive tech support help with changing the settings/goals on the app. However, there is no additional health coaching.

No Intervention: Waitlist Control

Participants are instructed to maintain their regular activities. Upon completion of the 16-week intervention, participants receive the "Jawbone UP2" activity monitor, education materials, and one session of tech support/health coaching.

Outcome Measures

Primary Outcome Measures

  1. Change in total volume of sedentary time (hours/day) [Baseline to 16-weeks]

    Change in the average number of hours/day of sedentary time measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

  2. Change in the number of breaks in sedentary time [Baseline to 16-weeks]

    Change in the average number of breaks in sedentary time measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

Secondary Outcome Measures

  1. Change in light physical activity [Baseline to 16-weeks]

    Change in the average number of hours per day spent in light physical activity (or higher intensity) measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

  2. Change in steps per day [Baseline to 16-weeks]

    Change in the average number of steps per day measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

  3. Change in physical performance [Baseline to 16-weeks]

    Change in the average physical performance score as measured by the Short Physical Performance Battery (SPPB). This performance battery includes chair stands, balance tests, and the 8-foot usual gait speed. Each subscale score ranges from 0 (cannot do) to 4 (good performance). The subscales are summed for a total score, which ranges from 0 (lowest level of performance) to 12 (highest level of performance)

  4. Change in physical functioning (ranging from basic to strenuous activities) [Baseline to 16-weeks]

    Change in self-reported physical functioning as measured by the 36-item Short Form Survey (SF-36) physical functioning subscale. Raw scores range from 0 (worst functioning) to 100 (best functioning)

  5. Change in health-related quality of life (self-reported mental, physical, and social health and well-being) [Baseline to 16-weeks]

    Change in quality of life as measured by the SF-36; each of the 8 subscales and 2 component summary scores; scores based on proprietary algorithm from Optum; higher scores represent better quality of life)

  6. Change in cardiometabolic markers [Baseline to 16-weeks]

    Change in fasting glucose, insulin and lipids, as well as high-sensitivity C-Reactive Protein (CRP)

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 60 years or older at the time of enrollment

  • Diagnosed with local or regionally staged cancer (any site) and completed primary treatment

  • Own a smartphone capable of running the "Jawbone UP2" app

  • Willingness to be randomized to any of the 3 study arms, attend 2 clinic visits, and wear activity monitors (activPAL and actiGraph) at weeks 1 and 16 for 7 days; "Jawbone UP2" wristband monitor during weeks 2-16 during waking hours.

  • Able to read, speak, and understand English.

  • Living independently and capable of walking 3 blocks (approximately 1300 steps or 0.25 mile) without an assistive device (e.g., cane, walker)

  • Residence within Bernalillo County or the four surrounding counties (to reduce travel burden)

Exclusion Criteria:
  • Currently participating in a program to decrease sedentary time or increase physical activity

  • Paid employment or volunteer position for greater than 20 hours per week

  • Severe impairments or pre-existing medical limitations for engaging in daily light physical activity

  • Wrist size >20 cm

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cindy Blair, PhD, MPH
  • University of New Mexico Cancer Center
  • American Cancer Society, Inc.

Investigators

  • Principal Investigator: Cindy K Blair, PhD, MPH, University of New Mexico

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cindy Blair, PhD, MPH, Principal Investigator, University of New Mexico
ClinicalTrials.gov Identifier:
NCT03632694
Other Study ID Numbers:
  • 16-003
  • INST UNM 1520
First Posted:
Aug 15, 2018
Last Update Posted:
Aug 15, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cindy Blair, PhD, MPH, Principal Investigator, University of New Mexico

Study Results

No Results Posted as of Aug 15, 2018